A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene

Gene Therapy

Volumn 11, Issue 19, 2004, Pages 1434-1440

  Yu, W ^a   Pirollo, K F ^a   Rait, A ^a   Yu, B ^a   Xiang, L M ^a   Huang, W Q ^a   Zhou, Q ^a   Ertem, G ^a   Chang, E H ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Gene delivery; Sterically stabilized immunolipoplexes; Systemic adminstarion; Tumor targeting

Indexed keywords

DNA; GREEN FLUORESCENT PROTEIN; IMMUNOLIPOSOME; LIPID; LUCIFERASE; MACROGOL; PROTEIN P53; RECEPTOR ANTIBODY; TRANSFERRIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GENETICS; CONTROLLED STUDY; DRUG CLEARANCE; DRUG COATING; DRUG TARGETING; ENZYME ACTIVITY; FIRST PASS EFFECT; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; INTERMETHOD COMPARISON; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; TIME; TREATMENT OUTCOME; TUMOR CELL;

ANIMALS; CELL LINE, TUMOR; DNA; FEMALE; GENE TARGETING; GENE THERAPY; GENETIC ENGINEERING; GENETIC VECTORS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; POLYETHYLENE GLYCOLS; PROSTATIC NEOPLASMS; RECEPTORS, TRANSFERRIN; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 5444231272     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302304     Document Type: Article

References (28)

1. Fenske DB, MacLachlan I, Cullis PR. Stabilized plasmid-lipid particles: a systemic gene therapy vector. Methods Enzymol 2002; 346: 36-71.
2. Woodle MC, Lasic DD. Sterically stabilized liposomes. Biochim Biophys Acta 1992; 1113: 171-199.
3. Blessing T et al. Different strategies for formation of pegylated EGF-conjugated PEI/DNA complexes for targeted gene delivery. Bioconjugate Chem 2001; 12: 529-537.
4. Guo W, Lee RL. Receptor-targeted gene delivery via folate-conjugated polyethylenimine. AAPS Pharm Sci 1999; 1: E19.
5. Chluba J, Lima DS, Frisch B, Schuber F. Enhancement of gene delivery by an analogue of alpha-MSH in a receptor-independent fashion. Biochim Biophys Acta 2001; 1510: 198-208.
6. Pun SH, Davis ME. Development of a nonviral gene delivery vehicle for systemic application. Bioconjugate Chem 2002; 13: 630-639.
7. Hofland HE et al. Folate-targeted gene transfer in vivo. Mol Ther 2002; 5: 739-744.
8. Kircheis R et al. Tumor-targeted gene delivery: an attractive strategy to use highly active effector molecules in cancer treatment. Gene Ther 2002; 9: 731-735.
9. Kursa M et al. Novel shielded transferrin-polyethylene glycolpolyethylenimine/DNA complexes for systemic tumor-targeted gene transfer. Bioconjugate Chem 2003; 14: 222-231.
10. Ogris M et al. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther 1999; 6: 595-605.
11. Kichler A et al. Intranasal gene delivery with a polyethylenimine-PEG conjugate. J Control Release 2002; 81: 379-388.
12. Gabizon A et al. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies. Bioconjugate Chem 1999; 10: 289-298.
13. Song LY et al. Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes. Biochim Biophys Acta 2002; 1558: 1-13.
14. Shi F et al. Interference of poly(ethylene glycol)-lipid analogues with cationic-lipid-mediated delivery of oligonucleotides; role of lipid exchangeability and non-lamellar transitions. Biochem J 2002; 366: 333-341.
15. Audouy S, de Leij L, Hoekstra D, Molema G. In vivo characteristics of cationic liposomes as delivery vectors for gene therapy. Pharm Res 2002; 19: 1599-1605.
16. Xu L, Pirollo KF, Chang EH. Transferrin-liposome-mediated p53 sensitization of squamous cell carcinoma of the head and neck to radiation in vitro. Hum Gene Ther 1997; 8: 467-475.
17. Xu L, Pirollo KF, Chang EH, Murray A. Systemic p53 gene therapy in combination with radiation results in human tumor regression. Tumor Targeting 1999; 4: 92-104.
18. Xu L et al. Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts. Hum Gene Ther 1999; 10: 2941-2952.
19. Xu L, Pirollo KF, Chang EH. Tumor-targeted p53 gene therapy enhances the efficacy of conventional chemo/radiotherapy. J Control Release 2001; 6: 115-128.
20. Xu L et al. Systemic p53 gene therapy of cancer with immunolipoplexes targeted by anti-transferrin receptor scFv. Mol Med 2001; 7: 723-734.
21. Xu L et al. Self-assembly of a virus-mimicking nanostructure system for efficient tumor-targeted gene delivery. Hum Gene Ther 2002; 13: 469-481.
22. Xu L et al. Systemic tumor-targeted gene delivery by anti-Transferrin receptor scFv-immunoliposomes. Mol Cancer Ther 2002; 1: 337-346.
23. Maruyama K, Ishida O, Takizawa T, Moribe K. Possibility of active targeting to tumor tissues with liposomes. Adv Drug Del Rev 1999; 40: 89-102.
24. Barron LG, Meyer KB, Szoka FC. Effects of complement depletion on the pharmacokinetics and gene delivery mediated by cationic lipid-DNA complexes. Hum Gene Ther 1998; 9: 315-323.
25. Dash PR et al. Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery. Gene Ther 1999; 6: 643-650.
26. Nishikawa M, Huang L. Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum Gene Ther 2001; 12: 861-870.
27. Chesnoy S, Huang L. Structure and function of lipid-DNA complexes for gene delivery. Annu Rev Biophys Biomol Struct 2000; 29: 27-47.
28. Yu W et al. Enhanced transfection efficiency of a systemically delivered tumor-targeting immunolipoplex by inclusion of a pH-sensitive histidylated oligolysine peptide. Nucleic Acids Res 2004; 32: e48.